Fundz

Samphire Neuroscience Raises $2.3M in Pre-seed Funding for Novel Neurotechnology Wearable Targeting PMS & Menstrual Pain

PRIVATEFeb 21, 2024

Amount Raised

$2.3 Million

Round Type

Pre-Seed

LondonBiotechnologyHealth Care

Investors

Rowena IronsideDr Pamela WalkerRussell BuckleyCVX VenturesAyuhSeasideAfterworkFirstpickSosv

Description

Samphire Neuroscience has successfully raised $2.3 million in pre-seed funding for its pioneering neurotechnology wearable, Nettle, designed to manage PMS and menstrual pain. The funding round drew contributions from venture firms experienced in medical devices and women’s health, as well as prominent angel investors.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Samphire Neuroscience that raised within 45 days of this round, from Fundz verified event records.

  • NeuroVigil raised $85M (Series B) on April 6, 2024.
  • Enlaza Therapeutics raised $84M on April 5, 2024.
  • Syntropic Medical raised an undisclosed amount (Funding Round) on April 5, 2024.
  • Mural Health raised $13M on April 5, 2024.
  • Beacon Therapeutics raised $120M (Series A) on April 5, 2024.
  • Curelo raised $1.2M (Seed) on April 4, 2024.

Who to call at Samphire Neuroscience, and when

A new round usually means Samphire Neuroscience is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Samphire Neuroscience raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Samphire Neuroscience, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Samphire Neuroscience. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Samphire Neuroscience

Location

London, England, United Kingdom

About

Samphire Neuroscience is a medtech startup focused on developing innovative neurotechnology solutions for women's health, with a particular emphasis on managing premenstrual syndrome (PMS) and menstrual pain.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Samphire Neuroscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Samphire Neuroscience's next move

See what Strategic adds

Samphire Neuroscience raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.